Excerpts from the documents of Mexican positions and recommendations in cardiovascular diseases and COVID-19

Marco A Alcocer-Gamba1, Pedro Gutiérrez-Fajardo2, Alfredo Cabrera-Rayo3

  • 1Sociedad Mexicana de Cardiología.

Insights

This study provides essential guidance for managing cardiovascular diseases during the COVID-19 pandemic. It offers recommendations for patient care, medical interventions, and public health strategies to address this unprecedented crisis.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has significantly impacted cardiovascular disease (CVD) management.
  • There is a need for updated, consensus-based recommendations for cardiologists and patients.

Purpose of the Study:

  • To present comprehensive recommendations for cardiovascular care during the COVID-19 pandemic.
  • To provide guidance on general measures, specific conditions, and interventions.

Main Methods:

  • A consensual review and analysis of scientific literature and positions.
  • Development of evidence-based recommendations by leading cardiology societies in Mexico.

Main Results:

  • Recommendations cover patient self-care, healthy lifestyle, and emergency response (cardio-respiratory arrest).
  • Guidance is provided on non-invasive imaging, pharmacotherapy, and management of hypertension, heart failure, arrhythmias, and acute coronary syndromes.
  • Specific focus on electrophysiology, interventional cardiology, cardiac surgery, and cardiac rehabilitation.

Conclusions:

  • These recommendations aim to orient the medical community in daily practice for patients with cardiovascular diseases amidst the COVID-19 crisis.
  • The guidelines ensure continuity of care and optimal management of cardiovascular conditions during the pandemic.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
204
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
110
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K